Table 8.

Local gamma passing rates ($2\%/2\hspace{0.17em}\text{mm}$, local normalization) for the COMPASS system, and mean global gamma passing rates ($2\%/2\hspace{0.17em}\text{mm}$ and $3\%/3\hspace{0.17em}\text{mm}$, global normalization to maximum with a low‐dose threshold at 10% of global maximum) for the COMPASS and Mobius3D systems. Results were extracted for the entire volume of the 12 real VMAT plans

	Total Gamma Passing Rates (%)
	H&N		Lung		Gastric		HRP		IRP		LRP
	Pat. 1	Pat. 2	Pat. 1	Pat. 2	Pat. 1	Pat. 2	Pat. 1	Pat. 2	Pat. 1	Pat. 2	Pat. 1	Pat. 2
Local Gamma $2\%/2\hspace{0.17em}\text{mm}$
CC	54.7	36.3	42.1	45.0	35.4	61.0	79.9	68.2	39.4	41.4	44.6	39.5
CR	29.0	18.4	36.0	45.0	46.2	57.1	51.4	56.2	42.6	39.3	43.8	43.2
Global Gamma $2\%/2\hspace{0.17em}\text{mm}$
M3D	92.7	99.1	97.7	97.8	96.5	81.8	94.6	95.7	98.8	98.7	98.4	99.0
CC	98.5	99.9	99.7	99.8	99.8	97.5	97.8	98.4	99.9	100.0	99.8	99.9
CR	93.8	99.3	98.8	97.8	98.1	95.1	93.2	96.9	98.9	96.6	97.6	98.4
Global Gamma $3\%/3\hspace{0.17em}\text{mm}$
M3D	99.6	99.9	99.7	99.9	99.9	97.6	99.7	100.0	100.0	99.9	99.9	100.0
CC	99.8	100.0	100.0	100.0	100.0	99.6	99.8	99.8	100.0	100.0	100.0	100.0
CR	98.4	99.8	99.8	99.7	99.9	99.3	99.2	99.7	99.9	99.0	99.5	99.8

$\mathrm{M}3\mathrm{D}=\text{Mobius}3\mathrm{D}$; $\text{CC}=\text{COMPASS dose calculation}$; $\text{CR}=\text{COMPASS dose reconstruction}$; $\mathrm{H}\&\mathrm{N}=\text{head and neck}$; $\text{HRP}=\text{high}‐\text{risk prostate}$; $\text{IRP}=\text{intermediate}‐\text{risk prostate}$; $\text{LRP}=\text{low}‐\text{risk prostate}$.